Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth
... become pregnant may cut their risk of having a premature
baby by half, according to research published ... of at least one year to reduced early premature
delivery rates of 50 to 70 percent, regardless of ... Of particular note is the drop in very early premature
births, those babies who are at the greatest risk ...
Preterm Births Rise 36 Percent Since Early 1980s
... are committed to raising public awareness about premature
birth, and we believe there are concrete steps we ... month, the March of Dimes issued its first-ever premature
Birth Report Card, which gave the United States a ... the health of babies by preventing birth defects, premature
birth and infant mortality. For the latest ...
National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
... reduce the instance of
cerebral palsy related to premature
Magnesium sulfate is traditionally used ... of reducing the
outcome of cerebral palsy in premature
Cerebral palsy is a group of ... cause of the disorder, risk factors
birth and low birth weight are directly ...
Folate in Strawberries May Contribute to Healthy Pregnancy
... New Study Links Folic Acid to Reduced premature
WATSONVILLE, Calif., Feb. 5 ... acid supplements greatly
reduced the risk of premature
birth. Meanwhile, federal health officials
say ... years, found it drastically reduced the
chance of premature
births, as well.
Folic acid, or folate, helps ...
Huge Drop in Preterm Birth-Risk Among Women Taking Folic Acid One Year Before Conception
... pregnant can cut their risk of having a premature
baby by half.
Researchers at the 28th Annual ... of at least one year to
reduced early premature
delivery rates of 50 to 70 percent, regardless ... pregnancy also may greatly
reduce the risk of premature
birth. These findings add even greater weight
Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
... Bubble CPAP system improves outcomes for premature
FORT WORTH, Texas, Dec. 10 ... the
incidence of chronic lung disease among premature
infants. One of two
hospitals in the Metroplex ... it comes to improving the lung
development of premature
Why HMFW Chose Bubble CPAP
PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
... of nonsense mutation genetic disorders. Nonsense mutations create a premature
stop signal in the mRNA causing the ribosome to terminate translation ... allow the ribosome to continue translation of the mRNA, by overriding the premature
stop signal leading to the formation of a functioning protein. Ataluren ...
Inhaled Nitric Oxide Data Presented at European Academy of Pediatrics Meeting
... "However, those
studies administered a higher dose of nitric oxide to premature
with an established higher risk of BPD. I believe the risk-dose ... in peer-review journals, and is active in the research
to prevent BPD in premature
infants with respiratory problems.
Ikaria Holdings, Inc. currently is ...
Leading Healthcare System Decreases MRSA Infection Rate by 53 Percent - Offers Protocol & Educational Materials Free of Charge to Other Organizations
campaign after Wiles was devastated by the death of a premature
MRSA and a MRSA outbreak in a Novant hospital neonatal unit.
Wiles learned the spread of MRSA to 18 premature
infants was a direct
result of hospital staff and physicians not properly ...
Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
... retinopathy," said Dr. Zimmer-Galler. Offering Quality Care to premature
Infants In a second study presented at the annual meeting, ... and image-based telemedicine examinations. "The number of premature
infants is increasing throughout the world,
and a larger percentage of ...
European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
... Women Who Take DHA Have Healthier Pregnancies, Fewer premature
GORDONSVILLE, Va., Aug. 29 /PRNewswire/ -- More than 50 ... birth weights. -- Women who include DHA in their diets have fewer premature
births. -- DHA intake is directly linked with improving infant mental and ...
Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results
... for lupus have been approved in almost 50 years and many currently used treatments are as toxic as the disease itself. Lupus is a leading cause of premature
cardiovascular disease, kidney disease and stroke among young women.
About the Lupus Research Institute
Pioneering d ...
Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
... procedure since the brain is without pain receptors.
In the developed world, major depression is second only to cardiovascular disease in premature
mortality and time lived with disability according to the review. In persons aged 15 to 44 years, depression is the most disabling medical illness in ...
MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
... is a known risk factor for severe RSV infection, there is little information available on risk factors among moderately (rather than extremely) premature
"The health risks associated with late-preterm birth may be overlooked or misunderstood because these babies often appear as healthy as ...
Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
... of the study suggest that oral and topical AC-11(R) products, when combined, are an inner and outer beauty solution to help reverse the signs of premature
The French research, which was sponsored by Itochu, compliments earlier published third party studies demonstrating the effectiveness of ...
CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis
... C-reactive protein
(hsCRP). The majority of patients had at least one other risk factor including
hypertension, low HDL-C, family history of premature
coronary heart disease
(CHD) or smoking. hsCRP is a recognized marker of inflammation which is
associated with an increased risk of atherosclerotic ...
CRESTOR(R) Reduced Risk of Blood Clots in the Veins
... C-reactive protein (hsCRP) and age. The majority of patients
had at least one other risk factor including hypertension, low HDL-C, family
history of premature
coronary heart disease (CHD) or smoking. hsCRP is a
recognized marker of inflammation which is associated with an increased risk
of atherosclerotic ...
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
... hyperhidrosis (8% vs. 1% placebo), palpitations (7% vs. 3% placebo), tachycardia (5% vs. 1% placebo), and hypertension (5% vs. 1%).
discontinuation rates (all causes including adverse event related) through the stable-dose treatment period of the trial were 31% for patients ...
CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
... C-reactive protein (hsCRP) and age. The majority
of patients had at least one other risk factor including hypertension, low
HDL-C, family history of premature
coronary heart disease (CHD) or smoking.
hsCRP is a recognized marker of inflammation which is associated with an
increased risk of atherosclerotic ...
March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition
... chapters nationwide and its premier event, March for
Babies(R), the March of Dimes works to improve the health of babies by
preventing birth defects, premature
birth and infant mortality. For the
latest resources and information, visit marchofdimes.com or nacersano.org.
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
cariprazine vs. -8.5 placebo, p < 0.0001) and the observed-cases (OC)
analysis (-19.1 cariprazine vs. -13.6 placebo, p < 0.0001).
discontinuation rates (all causes, including adverse
event related) were 36 % for patients receiving cariprazine and 38% for
patients receiving ...
Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
... advancement in addressing this significant unmet clinical need.
If left untreated, moderate heart failure is a debilitating disease that
can lead to premature
death. We believe that C-Pulse represents one of the
most innovative therapies in development for this indication in patients
who no longer receive ...
Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
... According to the World Health Organization, in the United States
alone, preeclampsia is responsible for 18 percent of all maternal deaths,
births and numerous neonatal complications, and costs more
than $7 billion in healthcare costs annually. With early detection, it may
be possible to ...
Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
... from all four cohorts showed a median reduction in plasma viral
load at nadir of 1.8 - 2.0 log copies/mL. There were no serious adverse
discontinuations, clinically relevant ECGs changes or
drug-related rash reported in any cohort. The incidence of CNS side effects
was similar between ...
Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
... layers of the brain and spinal
cord. If unchecked, over time the immune system attack on myelin leads to
poor coordination, severe disabilities and premature
death. Annual sales of
interferon beta were estimated to be $4.3 billion in 2007.
"This generous new grant from the OCS is an important ...
New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans
... is the leading nonprofit organization for pregnancy
and baby health. Its mission is to improve the health of babies by
preventing birth defects, premature
birth and infant mortality. For the
latest resources and information, visit marchofdimes.com or nacersano.org.
Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
... dose on
an empty stomach showed an increase in gastrointestinal side effects, but
these effects were generally transient and mild.
-- There were no premature
discontinuations in any cohort.
-- Based on the results generated in this trial, the doses planned for
the Phase 2b program will be 600 mg, 800 mg ...
Genzyme and Isis Complete Licensing of Mipomersen
... is currently in phase 3 development for
patients with homozygous familial hypercholesterolemia, a disease which
creates a greatly increased risk of premature
cardiovascular disease (CVD)
and CVD-related death. In phase 2 studies, mipomersen, a weekly injectable
therapeutic, was observed to reduce ...
Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
... deformities. Unless the
inflammatory processes are halted or controlled, the disease will lead to
disability, co-morbidities, and in many cases also premature
About Genmab A/S Genmab is a leading international biotechnology
company focused on developing fully human antibody therapeutics for ...
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
... skin rash or any other sign of
In late pregnancy, as with other NSAIDs, FLECTOR(R) Patch should be
avoided because it may cause premature
closure of the ductus arteriosus.
Please see complete prescribing information for FLECTOR(R) Patch available
at http://www.FlectorPatch.com .
Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
... disease in high-risk infants. RSV is a
leading cause of viral respiratory infection among preterm infants.
Approximately 4,000 medical records from premature
infants born at
32-to-35 weeks gestational age were reviewed. Fifty percent of those
infants received Synagis. RSV prophylaxis was requested, but ...
Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
... hospitalization as
a result of RSV (p=<0.001). Reductions were observed in both children with
bronchopulmonary dysplasia (38 percent reduction) and premature
without BPD (78 percent reduction). Approximately 50 percent of the
children in the analysis had BPD.
For full prescribing information for ...
STARscanner, STARband Cranial Helmets Making a Difference in the Lives of Children
... S.C., April 30 /PRNewswire/ -- At five months of age,
Amelia Sandin of Charleston was diagnosed with craniosynostosis, a
condition that leads to premature
fusion of the cranial sutures, or
fontanels, causing problems with normal brain and skull growth.
After undergoing surgery to correct the ...
Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
... LDL-cholesterol due to a
genetic disorder which prevents proper metabolism of LDL-cholesterol. These
patients experience a markedly increased risk of premature
diseases (CVD) and CVD-related death. FH can be present in two forms:
homozygous (hoFH), where the same defective gene is inherited ...
Reduced Lung Capacity Accelerates With Diabetes
... that, in people who exhibit cardiometabolic risk
factors (such as insulin resistance, hypertension, overweight/obesity, or a
family history of premature
heart disease), a certain protein called
apolipoprotein B (ApoB) may better predict the risk of heart disease than
LDL cholesterol levels, long used ...
Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
... the literature suggests
that all men will get prostate cancer if they live long enough, there is no
reason to accelerate the process or undergo a premature
biopsy, where the
patient assumes all of the risk. To reiterate, a 3.0 Tesla MRI-S scan
creates a roadmap to guide targeted biopsies to the specific ...
PTC Therapeutics Announces Publication of Preclinical Data in PNAS
... the results published in PNAS
further demonstrate that PTC124 targets genetic mutations in a completely
new way. PTC124 functions by overcoming the premature
stop signal and
reading through the complete genetic instructions, resulting in the
restoration of a full-length, functional protein. Patients with ...
Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
... overall aesthetic result.
The 4% hydroquinone-based skin care program, known commercially as the
Obagi(R) Condition & Enhance System, helps correct premature
and prevent future skin damage. The system is comprised of products that
work together to improve overall skin health and appearance. ...
Nobel Prize-Winning Discovery
... But those who live with the disease have serious breathing
difficulty, overproduction of mucus, intestinal blockage, liver damage and,
Gene therapy, though in the early stages of research, aims to knock out
human disorder-causing genes, among other functions. Eventually, ...
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
... (2.10 vs. 4.22, P<0.001).
"PNH is a progressive disease that damages vital organs, increases the
risk of dangerous blood clots and can lead to premature
kidney disease is a significant concern in these patients because it often
goes undetected, and kidney function can decline gradually ...